PD-L1 expression allows tumor cells to escape anti-tumor cytotoxic immunity and has been described to worsen the prognosis of several gastrointestinal malignancies, including gastric cancer36–39, esophageal cancer40,41, and specific subtypes of pancreatic cancer42,43. Here, CD274 is linked to neoplasm.